LAYTH HAKIM: Open Payments
NPI 1386783785 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 67 payments from 16 companies in 2025. Trend: 2023 $209 · 2024 $958 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $277 |
| Alkermes, Inc. | 10 | $165 |
| ABBVIE INC. | 9 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $133 |
| Lundbeck LLC | 4 | $95 |
| Corium, LLC | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| Almatica Pharma LLC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
Products named: REXULTI, VRAYLAR, LYBALVI, CAPLYTA, Azstarys, ABILIFY ASIMTUFII, INGREZZA, Jornay PM.
Industry payments across TX — which companies pay providers there.
